Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Disease × Calcium Dobesilate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 106 Precursor Cell Lymphoblastic Leukemia-Lymphoma 37 Leukemia 23 Lymphoma 20 Recurrence 16 Burkitt Lymphoma 15 Lymphoma, Mantle-Cell 13 Neoplasms, Plasma Cell 11 Lymphoma, Non-Hodgkin 11 Waldenstrom Macroglobulinemia 9 Lymphoma, Follicular 9 Immunoglobulin Light-chain Amyloidosis 9 Hodgkin Disease 9 Breast Neoplasms 9 Vomiting 8 Neoplasms 8 Nausea 8 Lymphoma, B-Cell, Marginal Zone 8 Lymphoma, Large B-Cell, Diffuse 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, T-Cell, Cutaneous 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Amyloidosis 6 Leukemia, Myeloid, Acute 5 Smoldering Multiple Myeloma 4 Sezary Syndrome 4 Mycosis Fungoides 4 Lymphoma, Large-Cell, Immunoblastic 4 Lung Neoplasms 4 Blast Crisis 4

Interventions

Dexamethasone 5 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 Blood Specimen Collection 4 Surveys and Questionnaires 3 Prednisone 3 Melphalan 3 Lenalidomide 3 Biopsy, Fine-Needle 3 fluciclovine F-18 2 carfilzomib 2 Positron-Emission Tomography 2 Mammography 2 Injections 2 Immunohistochemistry 2 Gemcitabine 2 Cytarabine 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 weifuchun 1 vistusertib 1 venetoclax 1 technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1 ricolinostat 1 pomalidomide 1 phosphoribosylformylglycinamidine synthetase 1 pembrolizumab 1 ofatumumab 1 obinutuzumab 1 lortalamine 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01857115 2024-11-13

wCCyd

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡